| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Vollenweider FX, Leenders... |
Positron emission tomography and fluorodeoxyglucose studies of metabol... |
Neuropsychopharmacol... |
1997 |
| Hasler F, Bourquin D, Bre... |
Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma ... |
Pharm Acta Helv |
1997 |
| Vollenweider FX, Gamma A,... |
Psychological and cardiovascular effects and short-term sequelae of MD... |
Neuropsychopharmacol... |
1998 |
| Vollenweider FX, Vollenwe... |
Psilocybin induces schizophrenia-like psychosis in humans via a seroto... |
Neuroreport |
1998 |
| Gamma A, Frei E, Lehmann ... |
Mood state and brain electric activity in ecstasy users |
Neuroreport |
1999 |
| Vollenweider FX, Gamma A,... |
Is a single dose of MDMA harmless? |
Neuropsychopharmacol... |
1999 |
| Vollenweider FX, Remensbe... |
Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensor... |
Psychopharmacology (... |
1999 |
| Vollenweider FX, Vontobel... |
5-HT modulation of dopamine release in basal ganglia in psilocybin-ind... |
Neuropsychopharmacol... |
1999 |
| Gamma A, Buck A, Berthold... |
3,4-Methylenedioxymethamphetamine (MDMA) Modulates Cortical and Limbic... |
Neuropsychopharmacol... |
2000 |
| Liechti ME, Baumann C, Ga... |
Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA... |
Neuropsychopharmacol... |
2000 |
| Liechti ME, Saur MR, Gamm... |
Psychological and Physiological Effects of MDMA ('Ecstasy') after Pret... |
Neuropsychopharmacol... |
2000 |
| Gamma A, Buck A, Berthold... |
Erratum. 3, 4-methylenedioxymeth-amphetamine (MDMA) modulates cortical... |
Neuropsychopharmacol... |
2000 |
| Liechti ME, Vollenweider ... |
Acute psychological and physiological effects of MDMA ('Ecstasy') afte... |
Eur Neuropsychopharm... |
2000 |
| Liechti ME, Vollenweider ... |
The serotonin uptake inhibitor citalopram reduces acute cardiovascular... |
J Psychopharmacol |
2000 |
| Vollenweider FX, Gucker P... |
Effects of MDMA on 5-HT uptake sites using PET and [11C]-McN5652 in hu... |
Conference of the Ge... |
2000 |
| Gamma A, Buck A, Berthold... |
No difference in brain activation during cognitive performance between... |
J Clin Psychopharmac... |
2001 |
| Frei E, Gamma A, Pascual-... |
Localization of MDMA-induced brain activity in healthy volunteers usin... |
Human Brain Mapp |
2001 |
| Liechti ME, Gamma A, Voll... |
Gender Differences in the Subjective Effects of MDMA |
Psychopharmacology |
2001 |
| Liechti ME, Geyer MA, Hel... |
Effects of MDMA (Ecstasy) on Prepulse Inhibition and Habituation of St... |
Neuropsychopharmacol... |
2001 |
| Vollenweider FX, Jones RT... |
Caveat Emptor: Editors Beware (reply) |
Neuropsychopharmacol... |
2001 |
| Liechti ME, Vollenweider ... |
Which neuroreceptors mediate the subjective effects of MDMA in humans?... |
Hum Psychopharmacol ... |
2001 |
| Vollenweider FX, Geyer MA |
A systems model of altered consciousness: integrating natural and drug... |
Brain Res Bull |
2001 |
| Vollenweider FX |
Brain mechanisms of hallucinogens and entactogens |
Dialogues Clin Neuro... |
2001 |
| Vollenweider FX, Liechti ... |
Acute psychological and neurophysiological effects of MDMA in humans |
J Psychoactive Drugs |
2002 |
| Hasler F, Bourquin D, Bre... |
Renal excretion profiles of psilocin following oral administration of ... |
J Pharm Biomed Anal |
2002 |
| Umbricht D, Vollenweider ... |
Effects of the 5-HT(2A) Agonist Psilocybin on Mismatch Negativity Gene... |
Neuropsychopharmacol... |
2002 |
| Hasler F , Grimberg U, Be... |
Acute psychological and physiological effects of psilocybin in healthy... |
Psychopharmacology |
2004 |
| Carter OL, Pettigrew JD, ... |
Modulating the Rate and Rhythmicity of Perceptual Rivalry Alternations... |
Neuropsychopharmacol... |
2005 |
| Vollenweider FX, Liechti ... |
MDMA affects both error-rate dependent and independent aspects of deci... |
J Psychopharmacol |
2005 |
| Wittmann M, Carter O, Has... |
Effects of psilocybin on time perception and temporal control of behav... |
J Psychopharmacol |
2006 |
| Vollenweider FX, Kometer ... |
The neurobiology of psychedelic drugs: implications for the treatment ... |
Nat Rev Neurosci |
2010 |
| Quednow BB, Kometer M, Ge... |
Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are... |
Neuropsychopharmacol... |
2012 |
